Target intelligence / Profile preview

Novel transcript, antisense to CCDC150 (ENSG00000282836)

Target
ENSG00000282836
Molecular classification
Other, Natural antisense transcript, non-coding RNA
01

Overview

ENSG00000282836 represents a non-coding RNA transcript characterized as a "novel transcript, antisense to CCDC150". As an antisense RNA (natural antisense transcript; NAT), it is transcribed in the opposite direction to the CCDC150 gene. Such antisense transcripts can regulate their corresponding sense genes through diverse post-transcriptional mechanisms, including transcriptional interference, chromatin remodeling, RNA masking, and the generation of double-stranded RNA, thereby modulating gene expression at multiple levels. However, there is no evidence that ENSG00000282836 acts as a therapeutic target (such as a receptor, enzyme, transporter), nor are there any known drugs or biomarkers directly associated with this transcript. Its functional impact, if any, would relate to gene expression control rather than direct protein-coding activity[1][3][5].

02

Biological functions

Regulation of gene expressiontranscriptional interferenceRNA maskingdsRNA-dependent mechanismschromatin remodeling
03

Disease associations

Other

Beyond the preview

Go deeper on Novel transcript, antisense to CCDC150 (ENSG00000282836).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to CCDC150 (ENSG00000282836).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call